FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Outlines Guidance on Combating Opioid Addiction

As part of its ongoing efforts to address the opioid epidemic, FDA releases a draft guidance to help sponsors develop medication-assisted treatments a...

Medical Devices

FDA Clears Varians Calypso Anchored Beacon Transponder

FDA clears a Varian 510(k) for its Calypso Anchored Beacon transponder for treating lung tumors.

Human Drugs

Bruker Daltonik Gains Marketing OK for C. auris Detection

FDA allows the de novo marketing for Bruker Daltoniks Bruker Maldi Biotyper CA system for identifying C. auris.

Human Drugs

Consent Decree Against Violative Drug Compounder

A federal judge in Arkansas enters a consent decree of permanent injunction between FDA and drug compounder Cantrell Drug Co. and its CEO James L. McC...

FDA General

Arthritis Advisory Committee Renewed for 2 Years

Federal Register notice: FDA announces the renewal of its Arthritis Advisory Committee for an additional two years beyond the charter expiration date.

Human Drugs

FTC Appeals Shire Vancocin Case Dismissal

Attorney Jennifer Thomas says the FTC decision to appeal an adverse ruling in its Vancocin case against Shire demonstrates its concern with the lower ...

Federal Register

Draft Guide on Inhalation Drug Products

Federal Register notice: FDA makes available a draft guidance entitled Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products Quality ...

Medical Devices

SpeeDx M. genitalium Test Cleared by FDA

FDA clears a SpeeDx 510(k) for its ResistancePlus MG Positive Control kit, a diagnostic test that simultaneously detects M. genitalium and genetic mar...

Medical Devices

Court Says Lap-Band Claims Preempted

Attorney Michelle Yeary says an Alabama federal court has ruled that all of a plaintiffs claims against Allergan charging negligence and other issues ...

Human Drugs

Advisors Unanimously Back GW Cannabidiol Drug

The FDA Central Nervous System Drugs Advisory Committee unanimously recommends approval of GW Pharmas Epidiolex, a cannabidiol drug to treat to rare c...